Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-06

Clinical Trial Update: Test Albuvirtide in Experienced Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update for albuvirtide in experienced HIV/AIDS patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • albuvirtide (albuvirtide)

Snippet

Sponsor: Frontier Biotechnologies Inc. | Conditions: HIV Infections, AIDS | Phase 3 | Status: COMPLETED